Tempus
Senior Scientist I, Applied Machine Learning and Generative AI, Pharma R&D
$140K–$210K
Boston +2 · Senior · Full-time · Posted Oct 20, 2026
- Location
- Boston
Chicago
New York City - Experience
- A PhD plus 2+ years of relevant industry or postdoctoral experience, or a master’s degree with 2+ years of relevant experience plus an additional 2+ years of relevant industry or postdoctoral experience.
- Education
- PhD, or master’s degree with 2+ years of relevant experience.
About the job
Develops computational analyses, algorithms, causal models, and AI tools that support pharmaceutical research and drug development on the Tempus platform.
What you'll do
- Build and improve machine learning, generative AI, causal modeling, and agent-based capabilities for pharmaceutical R&D.
- Collaborate with Tempus teams and pharmaceutical partners to develop solutions and communicate scientific findings to stakeholders.
- Coach computational biology and real-world evidence scientists on AI tools and adoption.
What they ask for
- PhD, or a master’s degree with 2+ years of relevant experience, plus an additional 2+ years of relevant industry or postdoctoral experience.
- Quantitative/computational skills in causal AI, causal inference, or explainable AI, along with biological, medical, or drug-development knowledge.
- Proficiency in R, Python, and SQL; machine learning and statistical modeling expertise, including hands-on causal methods.
- Experience with LLM-driven agent architectures, prompt engineering, RAG, and function calling/tool use; peer-reviewed publications.
Nice to have
- Integrative modeling of multimodal clinical and omics data.
- Understanding of cancer biology and experience with transcriptome, NGS, clinical, or real-world medical data.
Pay
$140,000-$200,000 USD base salary; $150,000-$210,000 USD base salary
Tools
R, Python, SQL, LangChain, LangGraph, AutoGen, DSPy
AI focus
Develops and applies machine learning, causal AI, generative AI, LLM agents, and foundation models for pharmaceutical R&D.
Model-written summary · the original posting is authoritative